R. Bambauer, P. Mestres, R. Schiel, et al., “New Surface Treatment Technologies for Catheters Used for Extracorporeal Detoxication Methods,” Dialysis & Transplantation, Vol. 24, No. 5, 1995, pp. 228-237. [28] P. Sioshansi, “Ion Implantation of Cobalt Chronicum Prosthetic Components to Reduce Polyethylene Wear,” Orthopedics Today, Vol. 11, No. 1, 1991, pp. 24-25. [29] D. Schierholz, A. Rump and W. Pulverer, “Klinische und Praklinische Effizienz Antimikrobieller Katheter,” Anaesthesiol Intensivmed Notfallmed Schmerzther, Vol. 32, No. 5, 1997, pp. 289-305. doi:10.1055/s-2007-995058 [30] R. Bambauer, R. Schiel, C. Bambauer and R. Latza, “Surface-Treted versus Untreated Large-Bore Catheters as Vascular Access in Hemodialysis and Apheresis,” International Journal of Nephrology, Vol. 2012, 2012, Article ID: 956136, 8 pages. http://www.Hindawi.com/journals/ijn(2012/956136/ [31] R. Vanholder, N. Hoenich, S. Ringoir, et al., “Morbidity and Mortality of Central Venous Catheter Hemodialysis, a Review of 10 Years’ Experience,” Nephron, Vol. 47, No. 4, 1987, pp. 247-279. doi:10.1159/000184523 [32] G. Jean, B. Charra, C. Chazot, et al., “Risk Factor Analysis for Long-Term Tunnelled Dialysis Catheter-Related Bacteremias,” Nephron, Vol. 91, No. 2, 2002, pp. 399-405. doi:10.1159/000064279 [33] S. H. Kim, K. I. Song, J. W. Chang, et al., “Prevention of Uncuffed Hemodialysis Catheter-Related Bacteremia Using an Antibiotic Lock Technique: A Prospective, Randomised Clinical Trial,” Kidney International, Vol. 69, No. 1, 2006, pp. 161-164. doi:10.1038/sj.ki.5000012 [34] E. A. King, D. McCoy, S. Desai, et al., “Vancomycin Resistant Enterococcal Bacteraemia and Daptomycin: Are Higher Doses Necessary?” Journal of Antimicrobial Chemotherapy, Vol. 66, No. 9, 2011, pp. 2112-2118. doi:10.1093/jac/dkr255 [35] I. Cui, A. Iwamoto and I. O. Lian, “Novel Mechanism of Antibiotic Resistance Originating in Vancomycin-Intermediate Staphylococcus aureus,” Antimicrobial Agents and Chemotherapy, Vol. 50, No. 2, 2006, pp. 428-438. doi:10.1128/AAC.50.2.428-438.2006 [36] I. Cui, F. Tominage, H. M. Nenh, et al., “Correlation between Reduced Daptomycin Suscetibility and Vancomycin Resistance in Vancomycin-Intermediate Staphylococcus aureus,” Antimicrobial Agents and Chemotherapy, Vol. 50, No. 3, 2006, pp. 1079-1082. doi:10.1128/AAC.50.3.1079-1082.2006 [37] D. G. Maki, J. K. Garman, J. M. Shapiro, et al., “An Attachable Silver-Impregnated Cuff for Prevention of Infection with Central Venous Catheters: A Prospective Randomized Multicenter Trial,” The American Journal of Medicine, Vol. 85, No. 3, 1988, pp. 307-314. doi:10.1016/0002-9343(88)90579-7 [38] K. S. Tweden, J. D. Cameron, A. J. Razzouk, et al., “Silver Modification of Polyethylene Terphthalate Textile for Antimicrobial,” ASAIO Journal, Vol. 43, No. 2, 1997, pp. M475-M481. doi:10.1097/00002480-199703000-00088 [39] A. Oloffs, C. Gosse-Siestrup, S. Bisson, et al., “Biocompatibility of Silver Coated Polyurethane Catheters and Silver Coated Dacron Material,” Biomaterials, Vol. 15, No. 10, 1994, pp. 753-758. doi:10.1016/0142-9612(94)90028-0 [40] R. Bambauer, P. Mestres, R. Schiel, et al., “Surface Treated Large-Bore Catheters with Silver Based Coating Versus Untreated Catheters for Extracorporeal Detoxication Methods,” ASAIO Journal, Vol. 44, No. 4, 1998, pp. 3003-3008. doi:10.1097/00002480-199807000-00013 [41] K. S. Rabindranath, T. Bansal, J. Adams, et al., “Systematic Review of Antimicrobials for Prevention of Hemodialysis Catheter-Related Infections,” Nephrology Dialysis Transplantation, Vol. 24, No. 12, 2009, pp. 3763-3774. doi:10.1093/ndt/gfp327 [42] A. A. Hampton and R. J. Sheretz, “Vascular Access Infections in Hospitalised Patients,” The Surgical Clinics of North America, Vol. 68, No. 1, 1988, pp. 57-71. [43] C. Von Eif, W. Kohnen, K, Becker, et al., “Modern Strategies in the Prevention of Implant-Associated Infections,” The International Journal of Artificial Organs, Vol. 28, No. 11, 2005, pp. 1146-1156. [44] J. F. Timsit, O. Mimoz, B. Mourviller, et al., “Randomized Controlled Trial of Chlorhexidine Dressing and Highly Adhesive Dressing for Preventing Catheter-Related Infections in Critically Ill Adults,” American Journal of Respiratory and Critical Care Medicine, Vol. 186, No. 12, 2012, pp. 1272-1278. doi:10.1164/rccm.201206-1038OC [45] L. Troidle and F. O. Finkelstein, “Catheter-Related Bacteremia in Hemodialysis Patients: The Role of the Central Venous Catheter in Prevention and Therapy,” The International Journal of Artificial Organs, Vol. 31, No. 9, 2008, pp. 827-833. [46] S. Cicalini, F. Palmieri and N. Petrosillo, “Clinical Review: New Technologies for Prevention of Intravascular Catheter-Related Infections,” Critical Care, Vol. 8, 2004, pp. 157-162. doi:10.1186/cc2380 [47] G. Donelli, I. Francolini, A. Piozzi, et al., “New PolymerAntibiotic Systems to Inhibit Bacterial Biofilm Formation: A Suitable Approach to Prevent Central Venous CatheterAssociated Infections,” Journal of Chemotherapy, Vol. 14, No. 5, 2002, pp. 501-507. [48] S. Schmitt, G. Haase, E. Csomor, et al., “Inhibitor of Complement, Compstatin, Prevents Polymer-Mediated Mac-1 Up-Regulation of Human Neutrophils Independent of Biomaterial Type Tested,” Journal of Biomedical Materials Research, Vol. 66A, No. 3, 2003, pp. 491-499. doi:10.1002/jbm.a.10031 [49] M. R. Parsek, D. L. Val, B. L. Hanzelka, et al., “Acyl Homoserine-Lactone Quorum-Sensing Signal Generation,” Proceedings of the National Academy of Sciences of the United States of America, Vol. 96, No. 8, 1999, pp. 4360-4365. doi:10.1073/pnas.96.8.4360 [50] D. G. Davies, M. R. Parsek, J. P. Pearson, et al., “The Involvement of Cell-to-Cell Signals in the Development of a Bacterial Biofilm,” Science, Vol. 280, No. 5361, 1998, pp. 295-298. doi:10.1126/science.280.5361.295 [51] H. J. Feldmann, S. Kobrina and A. Wasserstein, “Hemodialysis Vascular Morbidity,” Journal of the American Society of Nephrology, Vol. 7, No. 4, 1996, 523-535. [52] S. Bambauer, “Cost Reduction Benefits of Applying an Antimicrobial Surface Treatment to Catheters,” Personnel Communication, 1996. [53] C. Schwebel, J. C. Lucet, A. Vesin, et al., “Economic Evaluation of Chlorhexidine-Impregnated Sponges for Preventing Catheter-Related Infection in Critically Ill Adults in the Dressing Study,” Critical Care Medicine, Vol. 40, No. 1, 2012, pp. 11-17. doi:10.1097/CCM.0b013e31822f0604 [54] P. J. Pronovost, C. A. Goeschel, E. Colantuoni, et al., “Sustaining Reductions in Catheter-Related Bloodstream Infections in Michigan Intensive Care Units: Observational Study,” British Medical Journal, Vol. 340, 2010, p. c309. doi:10.1136/bmj.c309 [55] E. Toccanelli, G. Smith, A. Hiske, et al., “Epidemiology, Medical Outcomes and Costs of Catheter-Related Bloodstream Infections in Intensive Care Units of Four European Countries: Literatureand Registry-Based Estimates,” Journal of Hospital Infection, Vol. 72, No. 2, 2009, pp. 97-103. doi:10.1016/j.jhin.2008.12.012 [56] N. P. O’Grady, M. Alexander, L. A. Burns, et al., “Guidelines for the Preventions of Intravascular Catheter-Related Infections,” Clinical Infectious Diseases, Vol. 52, No. 9, 2011, pp. e162-e193. [57] T. Nagai, S. Kohsaka, T. Anzai, et al., “Low Incidence of Catheter-Related Complications in Patients with Advanced Pulmonary Arterial Hypertension Undergoing Continuous Epoprostenol Infusions,” Chest, Vol. 141, No. 1, 2012, pp. 272-273.doi:10.1378/chest.11-1893

comments powered by Disqus

Copyright © 2020 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.